Adjunctive Corticosteroid Therapy for severe tuberculosis: Risk factors for poor outcomes?

Conclusion: Adjunctive corticosteroid therapy appears to offer significant short-term but (other than for tuberculous meningitis and effusive pericarditis) minimal long-term benefit for patients with tuberculosis.

Source: European Respiratory Journal - October 27, 2023 Category: Respiratory Medicine Authors: Nour Lahbib, J., Amani, B. M., Azza, S., Soumaya, B. S., Hafaoua, D., Fatma, T. Tags: Tuberculosis and non-tuberculous mycobacterial diseases Source Type: research